Company: BEP
Filing Date: 2025-11-12
Form Type: 424B5
Source: 0001193125-25-275856
Chunk: 11

Company: Brookfield Renewable Partners L.P.
Filing Date: 2025-11-12
Form: 424B5
Chunk 11
---
 Qualified Independent Underwriter will not be necessary for these offerings pursuant to FINRA Rule 5121(a)(1)(B), as the Partnership is offering securities which have a bona fide public market for purposes of Rule 
 5121. No underwriter having a Rule 5121 conflict of interest will be permitted under Rule 5121 to confirm sales to any account over which the underwriter exercises discretionary authority without the specific written approval of the accountholder. 
 See “Underwriting (Conflicts of Interest)”.                                                                                                                                                                                                             |

| Risk Factors | Investing in the LP Units involves risks. See “Risk Factors” on page S-3 of this Prospectus Supplement, on page 2 of the accompanying Prospectus, the risk factors included in the Annual Report and Q3 2025 Interim Report, and in 
 other documents we incorporate by reference in this Prospectus Supplement.                                                                                                                                                          |

| TSX Symbol | “BEP.UN” |

| NYSE Symbol | “BEP” |

S-2

RISK FACTORS

An investment in the LP Units involves a high degree of risk. Before making an investment decision, investors should carefully consider the
risks described under the heading “Risk Factors” in the Annual Report and the risk factors included in the Q3 2025 Interim Report and in other documents incorporated by reference in this Prospectus Supplement, as updated by the
Partnership’s subsequent filings with the SEC, pursuant to Sections 13(a), 14 or 15(d) of the Exchange Act, and securities regulatory authorities in Canada, which are incorporated in this Prospectus Supplement by reference. Any of these risks
could materially and adversely affect the Partnership’s business, properties, operations, results, financial condition, prospects or assets, which could in turn materially adversely affect the value of the LP Units. Additional risks and
uncertainties not currently known to the Partnership, or that are currently considered immaterial, may also materially and adversely affect the business, properties, operations, results, financial condition, prospects or assets of the Partnership.
For more information, see “Documents Incorporated by Reference”. In addition, please consider the following risks before making an investment decision:

The use of proceeds from this Offering is not certain.

We intend to use the net proceeds of this Offering and the Concurrent Private Placement to fund the recently completed acquisition of our
increased stake in Isagen S.A. E.S.P. (“Isagen”), future investment opportunities, and for general corporate purposes.

If all
or